NF-κB in the vascular progression of melanoma

被引:63
作者
Kashani-Sabet, M
Shaikh, L
Miller, JR
Nosrati, M
Ferreira, CMM
Debs, RJ
Sagebiel, RW
机构
[1] Univ Calif San Francisco, Ctr Canc, Cutaneous Oncol Program, Auerback Melanoma Res Lab & Melanoma Ctr, San Francisco, CA 94115 USA
[2] Calif Pacific Med Res Inst, San Francisco, CA USA
关键词
D O I
10.1200/JCO.2004.06.047
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To examine a model of melanoma progression based on vascular factors and the role of NF-kappaB in the vascular progression of melanoma. Patients and Methods A data set of 526 patients from the University of California San Francisco Melanoma Center with 2 years of follow-up or first relapse was studied. The impact of the presence or absence of various prognostic factors on overall survival of melanoma patients was assessed using Cox regression and Kaplan-Meier analysis. A matched-pair analysis of NF-kappaB expression was performed in cases with vascular involvement and increased tumor vascularity versus matched controls lacking these factors. Results Cox regression analysis of factors evaluated by the American Joint Committee on Cancer Melanoma Staging Committee reproduced the powerful impact of tumor thickness and ulceration in this data set. With the inclusion of vascular factors such as tumor vascularity and vascular involvement, ulceration was no longer significant in predicting overall survival. By multivariate analysis, vascular involvement and tumor vascularity were the strongest predictors of melanoma outcome. Tumor vascularity seems to be a precursor of both vascular involvement and ulceration. A matched-pair tissue array analysis demonstrated the significant correlation between overexpression of NF-kappaB-p65 and the development of vascular factors. Conclusion Vascular factors play an important role in the progression of malignant melanoma. Ulceration may be a surrogate marker for the interactions between melanoma and the tumor vasculature. NF-kappaB seems to play an important role in the development of these factors. (C) 2004 by American Society of Clinical Oncology.
引用
收藏
页码:617 / 623
页数:7
相关论文
共 40 条
  • [1] BALCH CM, 1980, CANCER-AM CANCER SOC, V45, P3012, DOI 10.1002/1097-0142(19800615)45:12<3012::AID-CNCR2820451223>3.0.CO
  • [2] 2-O
  • [3] Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
    Balch, CM
    Soong, SJ
    Gershenwald, JE
    Thompson, JF
    Reintgen, DS
    Cascinelli, N
    Urist, M
    McMasters, KM
    Ross, MI
    Kirkwood, JM
    Atkins, MB
    Thompson, JA
    Coit, DG
    Byrd, D
    Desmond, R
    Zhang, YT
    Liu, PY
    Lyman, GH
    Morabito, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3622 - 3634
  • [4] Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
    Balch, CM
    Buzaid, AC
    Soong, SJ
    Atkins, MB
    Cascinelli, N
    Coit, DG
    Fleming, ID
    Gershenwald, JE
    Houghton, A
    Kirkwood, JM
    McMasters, KM
    Mihm, MF
    Morton, DL
    Reintgen, DS
    Ross, MI
    Sober, A
    Thompson, JA
    Thompson, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3635 - 3648
  • [5] BALCH CM, 1992, ANAL PROGNOSTIC FACT, P165
  • [6] BARNHILL RL, 1992, LAB INVEST, V67, P331
  • [7] Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system
    Buzaid, AC
    Ross, MI
    Balch, CM
    Soong, SJ
    McCarthy, WH
    Tinoco, L
    Mansfield, P
    Lee, JE
    Bedikian, A
    Eton, O
    Plager, C
    Papadopoulos, N
    Legha, SS
    Benjamin, RS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1039 - 1051
  • [8] MODEL PREDICTING SURVIVAL IN STAGE-I MELANOMA BASED ON TUMOR PROGRESSION
    CLARK, WH
    ELDER, DE
    GUERRY, D
    BRAITMAN, LE
    TROCK, BJ
    SCHULTZ, D
    SYNNESTVEDT, M
    HALPERN, AC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24): : 1893 - 1904
  • [9] A STUDY OF TUMOR PROGRESSION - THE PRECURSOR LESIONS OF SUPERFICIAL SPREADING AND NODULAR MELANOMA
    CLARK, WH
    ELDER, DE
    GUERRY, D
    EPSTEIN, MN
    GREENE, MH
    VANHORN, M
    [J]. HUMAN PATHOLOGY, 1984, 15 (12) : 1147 - 1165
  • [10] Individualized prognosis for melanoma patients
    Cochran, AJ
    Elashoff, D
    Morton, DL
    Elashoff, R
    [J]. HUMAN PATHOLOGY, 2000, 31 (03) : 327 - 331